⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for peposertib

Every month we try and update this database with for peposertib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesNCT04068194
Cholangiocarcin...
Gallbladder Car...
Stage III Gallb...
Stage III Hilar...
Stage III Intra...
Stage IV Gallbl...
Stage IV Hilar ...
Stage IV Intrah...
Avelumab
Biopsy
Biospecimen Col...
Computed Tomogr...
Hypofractionate...
Peposertib
18 Years - National Cancer Institute (NCI)
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaNCT05711615
Metastatic Leio...
Metastatic Sarc...
Metastatic Soft...
Unresectable Le...
Unresectable Sa...
Unresectable So...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Pegylated Lipos...
Peposertib
18 Years - National Cancer Institute (NCI)
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian CancerNCT04092270
Endometrial Hig...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
FIGO Grade 1 En...
FIGO Grade 2 En...
Ovarian High Gr...
Ovarian Seromuc...
Ovarian Undiffe...
Platinum-Sensit...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Low G...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Recurrent Prima...
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Magnetic Resona...
Multigated Acqu...
Pegylated Lipos...
Peposertib
18 Years - National Cancer Institute (NCI)
Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or GliosarcomaNCT04555577
Glioblastoma
Gliosarcoma
Peposertib
Radiation Thera...
Resection
Temozolomide
18 Years - M.D. Anderson Cancer Center
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT04533750
Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT04533750
Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid LeukemiaNCT03983824
Recurrent Acute...
Refractory Acut...
Cytarabine
Etoposide Phosp...
Mitoxantrone Hy...
Peposertib
18 Years - National Cancer Institute (NCI)
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and M1774 for Advanced Solid TumorsNCT05687136
Advanced Malign...
Metastatic Mali...
Unresectable Ma...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Peposertib
Positron Emissi...
Tuvusertib
18 Years - National Cancer Institute (NCI)
Study of Peposertib in Combination With Capecitabine and RT in Rectal CancerNCT03770689
Locally Advance...
Peposertib 50 m...
Peposertib 100 ...
Peposertib 150 ...
Peposertib 250 ...
Capecitabine
Radiotherapy (R...
18 Years - EMD Serono
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and M1774 for Advanced Solid TumorsNCT05687136
Advanced Malign...
Metastatic Mali...
Unresectable Ma...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Peposertib
Positron Emissi...
Tuvusertib
18 Years - National Cancer Institute (NCI)
Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine TumorsNCT04750954
Neuroendocrine ...
Biospecimen Col...
Computed Tomogr...
Lutetium Lu 177...
Magnetic Resona...
Peposertib
18 Years - National Cancer Institute (NCI)
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyNCT04071236
Castration-Resi...
Metastatic Mali...
Metastatic Pros...
Stage IV Prosta...
Avelumab
Biospecimen Col...
Bone Scan
Computed Tomogr...
Magnetic Resona...
Peposertib
Questionnaire A...
Radium Ra 223 D...
18 Years - National Cancer Institute (NCI)
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic CancerNCT04172532
Locally Advance...
Locally Advance...
Stage II Pancre...
Stage III Pancr...
Unresectable Pa...
Biopsy
Biospecimen Col...
Computed Tomogr...
Hypofractionate...
Magnetic Resona...
Peposertib
Placebo Adminis...
18 Years - National Cancer Institute (NCI)
Study of Peposertib in Combination With Capecitabine and RT in Rectal CancerNCT03770689
Locally Advance...
Peposertib 50 m...
Peposertib 100 ...
Peposertib 150 ...
Peposertib 250 ...
Capecitabine
Radiotherapy (R...
18 Years - EMD Serono
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: